Cyprus - Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring
Since 2014, Cyprus Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring decreased by 2.8% year on year. In 2019, the country was ranked number 2 among other countries in Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring with $3,511,010.51. United States topped the ranking with $150,565,061.97 in 2019, +46.4% versus 2018. United States witnessed the best average annual growth at +89% per year, while Jordan recorded the worst performance at -19.6% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 3,511,010.51 |
| 2018 | 3,945,650.50 |
| 2017 | 2,649,009.00 |
| 2016 | 2,778,306.75 |
| 2015 | 2,845,679.25 |
Download all data from 2005 to 2019
How does Cyprus rank in Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring?
| # | 6 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
150,565,061.97 | 2019 | +46.4 % | +89.0 % | View data |
| 2 |
#2
Cyprus
|
3,511,010.51 | 2019 | -11.0 % | -2.8 % | View data |
| 3 |
#3
United Arab Emirates
|
1,405,592.50 | 2018 | -61.8 % | +12.5 % | View data |
| 4 |
#4
Canada
|
718,034.44 | 2019 | +110.4 % | +42.6 % | View data |
| 5 |
#5
Jordan
|
48,298.60 | 2018 | +53.9 % | -19.6 % | View data |